Castle Biosciences Inc’s recent filing unveils that its Officer Derek Maetzold acquired Company’s shares for reported $0.6 million on Sep 09 ’24. In the deal valued at $29.33 per share,20,583 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BRADBURY DANIEL sold 7,867 shares, generating $228,332 in total proceeds. Upon selling the shares at $29.02, the Director now owns 7,125 shares.
Before that, MAETZOLD DEREK J sold 699 shares. Castle Biosciences Inc shares valued at $21,004 were divested by the Pres. & Chief Exec. Officer at a price of $30.05 per share. As a result of the transaction, MAETZOLD DEREK J now holds 8,005 shares, worth roughly $0.23 million.
Guggenheim initiated its Castle Biosciences Inc [CSTL] rating to a Buy in a research note published on December 14, 2023; the price target was $25. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early January with a ‘”a Sector outperform”‘ rating. Stephens began covering CSTL with “an Overweight” recommendation on January 07, 2022. Lake Street started covering the stock on April 30, 2021. It rated CSTL as “a Buy”.
Price Performance Review of CSTL
On Tuesday, Castle Biosciences Inc [NASDAQ:CSTL] saw its stock fall -0.10% to $29.30. Over the last five days, the stock has gained 0.41%. Castle Biosciences Inc shares have risen nearly 35.77% since the year began. Nevertheless, the stocks have risen 59.76% over the past one year. While a 52-week high of $30.50 was reached on 08/30/24, a 52-week low of $12.07 was recorded on 07/05/24. SMA at 50 days reached $24.19, while 200 days put it at $22.36.
Levels Of Support And Resistance For CSTL Stock
The 24-hour chart illustrates a support level at 28.73, which if violated will result in even more drops to 28.16. On the upside, there is a resistance level at 29.69. A further resistance level may holdings at 30.09. The Relative Strength Index (RSI) on the 14-day chart is 61.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 29.56%. Stochastics %K at 70.85% indicates the stock is a holding.
How much short interest is there in Castle Biosciences Inc?
A steep rise in short interest was recorded in Castle Biosciences Inc stocks on 2024-08-15, dropping by -0.11 million shares to a total of 1.7 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 1.81 million shares. There was a decline of -6.33%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
